These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27821638)

  • 21. Prognostic Significance of Nuisance Bleeding in Anticoagulated Patients With Atrial Fibrillation.
    O'Brien EC; Holmes DN; Thomas LE; Fonarow GC; Allen LA; Gersh BJ; Kowey PR; Singer DE; Ezekowitz MD; Naccarelli GV; Ansell JE; Chan PS; Mahaffey KW; Go AS; Freeman JV; Reiffel JA; Peterson ED; Piccini JP; Hylek EM
    Circulation; 2018 Aug; 138(9):889-897. PubMed ID: 29678813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
    Cullen MW; Kim S; Piccini JP; Ansell JE; Fonarow GC; Hylek EM; Singer DE; Mahaffey KW; Kowey PR; Thomas L; Go AS; Lopes RD; Chang P; Peterson ED; Gersh BJ;
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):461-9. PubMed ID: 23759473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The introduction of novel oral anticoagulants in 2009 has been rightly heralded as a major therapeutic breakthrough.
    Pachinger O
    Wien Klin Wochenschr; 2014 Nov; 126(21-22):691. PubMed ID: 25398295
    [No Abstract]   [Full Text] [Related]  

  • 24. Anticoagulation in atrial fibrillation and co-existent chronic kidney disease: efficacy versus safety.
    Salim I; Al Suwaidi J; Ghadban W; Salam AM
    Expert Opin Drug Saf; 2013 Jan; 12(1):53-63. PubMed ID: 23095103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Appropriate dosing of nonvitamin K antagonist oral anticoagulants for stroke prevention in atrial fibrillation.
    Steinberg BA; Washam JB
    Trends Cardiovasc Med; 2017 Nov; 27(8):567-572. PubMed ID: 28750830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stroke prevention in atrial fibrillation patients with chronic kidney disease.
    Hart RG; Eikelboom JW; Brimble KS; McMurtry MS; Ingram AJ
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S71-8. PubMed ID: 23790601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticoagulation in Concomitant Chronic Kidney Disease and Atrial Fibrillation: JACC Review Topic of the Week.
    Kumar S; Lim E; Covic A; Verhamme P; Gale CP; Camm AJ; Goldsmith D
    J Am Coll Cardiol; 2019 Oct; 74(17):2204-2215. PubMed ID: 31648714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonvitamin K-dependent oral anticoagulants (NOACs) in chronic kidney disease patients with atrial fibrillation.
    Di Lullo L; Ronco C; Cozzolino M; Russo D; Russo L; Di Iorio B; De Pascalis A; Barbera V; Galliani M; Vitaliano E; Campana C; Santoboni F; Bellasi A
    Thromb Res; 2017 Jul; 155():38-47. PubMed ID: 28482261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What's New in Anticoagulation.
    Razavi JE; Safavi-Naeini P; Razavi M
    Tex Heart Inst J; 2016 Oct; 43(5):419-421. PubMed ID: 27777526
    [No Abstract]   [Full Text] [Related]  

  • 30. MY APPROACH to the practical management of anticoagulation in patients with atrial fibrillation.
    Flaker G
    Trends Cardiovasc Med; 2016 Apr; 26(3):292. PubMed ID: 26874917
    [No Abstract]   [Full Text] [Related]  

  • 31. Effectively Initiating and Maintaining Anticoagulation in Patients With Atrial Fibrillation.
    Wang TY
    Circulation; 2019 Apr; 139(15):1763-1765. PubMed ID: 30958715
    [No Abstract]   [Full Text] [Related]  

  • 32. Left atrial appendage closure in end-stage renal disease and hemodialysis: Data from a German multicenter registry.
    Fink T; Paitazoglou C; Bergmann MW; Sano M; Keelani A; Sciacca V; Saad M; Eitel C; Heeger CH; Skurk C; Landmesser U; Thiele H; Stiermaier T; Fuernau G; Reil JC; Frey N; Kuck KH; Tilz RR; Sandri M; Eitel I
    Catheter Cardiovasc Interv; 2023 Feb; 101(3):610-619. PubMed ID: 36682074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Warfarin, calciphylaxis, atrial fibrillation, and patients on dialysis: outlier subsets and practice guidelines.
    Eiser AR
    Am J Med; 2014 Apr; 127(4):253-4. PubMed ID: 24333618
    [No Abstract]   [Full Text] [Related]  

  • 34. [Atrial fibrillation and anticoagulation in hemodialysis patients: A complex decision].
    Delanaye P; Bouquegneau A; Dubois BE; Sprynger M; Mariat C; Krzesinski JM; Lancellotti P
    Nephrol Ther; 2017 Apr; 13(2):59-66. PubMed ID: 28216253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel oral anticoagulants to prevent stroke in atrial fibrillation.
    Verheugt FW
    Nat Rev Cardiol; 2010 Mar; 7(3):149-54. PubMed ID: 20179722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct oral anticoagulants for stroke prevention in atrial fibrillation: treatment outcomes and dosing in special populations.
    Stacy ZA; Richter SK
    Ther Adv Cardiovasc Dis; 2018 Sep; 12(9):247-262. PubMed ID: 30081727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New oral anticoagulants in non-valvular atrial fibrillation.
    Francia P; Adduci C; Santini D; Musumeci B; Tocci G
    High Blood Press Cardiovasc Prev; 2013 Jun; 20(2):53-60. PubMed ID: 23653173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New oral anticoagulants in elderly patients with atrial fibrillation.
    Deedwania PC
    Am J Med; 2013 Apr; 126(4):289-96. PubMed ID: 23369212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral anticoagulants to reduce the risk of stroke in atrial fibrillation: how should a clinician choose?
    Mohammed I; Syed W; Kowey PR
    Clin Cardiol; 2013 Nov; 36(11):663-70. PubMed ID: 23893881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Edoxaban in venous thromboembolism and stroke prevention: an appraisal.
    Proietti M; Lip GY
    Vasc Health Risk Manag; 2016; 12():45-51. PubMed ID: 27013883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.